No - I can't see a partnering scenario.
But given AGN's desire to treat brain injuries and EMV's desire to develop scanning equipment to identify brain injuries (using portable equipment that will fit in ambulances etc) ... there is a synergy.
And.
Intriguing how the exec overlap.
EMV equipment would help rationalise/prescribe the use of ARG-007 and, presumably, monitor the effectiveness of ongoing treatment accordingly.
Via a mobile platform ... thinking at car accidents, sports injuries, transport of stroke victims and so forth.
No - I can't see a partnering scenario. But given AGN's desire...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.010(1.28%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 78.0¢ | 80.5¢ | 78.0¢ | $71.40K | 90.43K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 78.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.5¢ | 2444 | 1 |
View Market Depth
| Last trade - 15.55pm 23/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |